US 12404275
Pyrazolopyrazine derived compounds, pharmaceutical composition and use thereof
granted A61PA61P35/00A61P37/02
Quick answer
US patent 12404275 (Pyrazolopyrazine derived compounds, pharmaceutical composition and use thereof) held by PrimeGene (Beijing) Co., Ltd. expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PrimeGene (Beijing) Co., Ltd.
- Grant date
- Tue Sep 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61P, A61P35/00, A61P37/02